Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on September 5, 2025
Back-to-Campus Shipping Services: Custom Crating for Research Labs and Academic Departments
EIN Presswire
·
September 5, 2025
This fall, Austin and Central Texas research labs and academic departments will get secure, damage-free shipping for microscopes, robotics, and R…
WRD Events 2025: Join GARC’s global community to create awareness around rabies
EIN Presswire
·
September 5, 2025
KS, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- For 2025, the World Rabies Day theme is Act Now: You, Me, Community. This year, GARC is calling on you, me, and our communities to take responsibility, work together, and drive real change. For …
Javier Palomarez, USHBC President, Hosts Q&A with Senators Ruben Gallego & Bernie Moreno on Small Business Priorities
EIN Presswire
·
September 5, 2025
WASHINGTON, DC, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- The United States Hispanic Business Council (USHBC) proudly hosted a Q…
Revive Therapeutics Announces Extension of Proposed Private Placement
GlobeNewswire
·
September 5, 2025
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …
AKT Health Announces Hakase AI to Transform Life Sciences with a Comprehensive AI Platform
EIN Presswire
·
September 5, 2025
Hakase AI unites Clinical, Commercial …
Global Leaders to Explore AI, Health Equity & Digital Innovation at Healthark’s RWEsearch & Health Innovation Summit
EIN Presswire
·
September 5, 2025
55+ experts, 20+ sessions: RWEsearch …
Komal Dangi Joins AptaPharma as Managing Partner, Ushering in a New Era of Innovation and Strategic Growth
EIN Presswire
·
September 5, 2025
Komal Dangi Joins AptaPharma as Managing Partner, Ushering in a New Era of Innovation and Strategic Growth PENNSAUKEN NJ, NJ, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- AptaPharma Inc., a rising force in the pharmaceutical industry …
Bone Cement Market Projected to Reach USD 1.2 Bn, Expand at a CAGR of 5.2% by 2035 | Analysis Report by TMR
EIN Presswire
·
September 5, 2025
The Global Bone Cement Market Growth at a CAGR of 5.2%, Driven by Ongoing Advancements in Surgical Techniques 2035 WILMINGTON, DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- The global Bone Cement Market is a vital and growing segment of the …
Water for Injection Market Anticipated to Reach USD 71.7 Bn, Expand at a CAGR of 8.0% by 2035 | Analysis Report by TMR
EIN Presswire
·
September 5, 2025
The Global Market for Water for Injection Market Grow at a CAGR of 8.0% by 2035 : Growing Adoption of Single-Use Systems in Pharmaceutical Manufacturing WILMINGTON, DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- The global Water for …
Waanee AI Partners with Digitide to Deliver Human-Centered Conversational AI for Enterprise CX
EIN Presswire
·
September 5, 2025
Waanee AI partners with Digitide to deliver blended human + AI CX, empowering agents, scaling service, and preserving human judgment. DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Waanee AI Inc., a Delaware-registered conversational AI …
Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta
GlobeNewswire
·
September 5, 2025
Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance, a nonprofit dedicated to improving public health outcomes, announced today that Dr. Rahul Gupta, former director of the White House Office of National Drug Control Policy, will headline …
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
GlobeNewswire
·
September 5, 2025
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company, …
DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq
GlobeNewswire
·
September 5, 2025
Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une société …
Publication relating to transparency notifications
GlobeNewswire
·
September 5, 2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 5, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large …
Publication relative à des notifications de transparence
GlobeNewswire
·
September 5, 2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 5 septembre 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
GlobeNewswire
·
September 5, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
GlobeNewswire
·
September 5, 2025
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …